AntiCancer

Product Details:

BDENZA is a prescription drug manufactured by BDR Pharma. This medicine is used in the treatment of Prostate Cancer.

Product Details:

Sorafenib is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).

Sorafenib is a small molecular inhibitor of several Tyrosine protein kinases. (Protein kinases are overactive in many of the molecular pathways that cause cells to become cancerous). Sorafenib works along the multiple signaling pathways to block cell proliferation and tumor angiogenesis. It blocks the receptor tyrosine kinases VEGFR (Vascular Endothelial Growth Factor Receptor) and PDGFR (Platelet Derived Growth Factor Receptor) and the RAF serine/threonine kinases along the RAF/MEK/ERK pathway.

Indications:
RCC – Locally Advanced / Metastatic clear cell Renal cell carcinoma in patients, who have failed or unsuitable for cytokine therapy.
HCC – Unresectable hepatocellular carcinoma.

Dosage & Usage :

• High fat meal may decrease oral bioavailability of Sorafenib.
• Orally at least 1 hour before or 2 hours after a meal.
• Drug Interactions :
• Potential pharmacokinetic interaction with doxorubicin and irinotecan (increased area under the serum concentration-time curve [AUC] of doxorubicin and of irinotecan and its active metabolite SN-38).
• Does not appear to affect the pharmacokinetics of or oxaliplatin.

Side Effects:

• Hypophosphatemia, Diarrhea, Increased Lipase Concentrations, Rash/Desquamation, Fatigue,
• Hand-foot Syndrome,
• Increased Amylase Concentrations,
• Alopecia,
• Nausea, Lymphopenia, Pruritus, Neutropenia, Hypertension, Anorexia, Vomiting, Constipation,

Hemorrhage Dyspnea, Cough, Sensory Neuropathy, Dry Skin, Pain (Abdominal, Joint, Headache, Mouth, Bone, And Tumor), Weight Loss, Erythema, Asthenia, And Leukopenia

Note:
SORANIB is to be used under proper medical guidance and advice.

Product Details:

Product Details:

Product Details:

Each film coated tablet contains eltrombopag olamine equivalent to 25 mg eltrombopag as eltromobopag free acid.

Product Details:

Product Details:

Lyophilied
For Bolus Intravenous Injection For Single Use Only

Product Details:

Lyophilied
For Bolus Intravenous Injection For Single Use Only

Product Details:

Zecyte or Xbira 250 mg Abiraterone Acetate Tablet is a prostate cancer drugs Manufactured By Cipla Limited in India which is helpful for prostate cancer treatments. For Oral Use
Warning: Keep Out of Reach of Children

Product Details:

Each Film Coated Tablets Contains:
Erlotinib Hydrochloride IP Equivalent to Erlotinib 150 mg

Colour:
Titanium Dioxide

Dosae:
As Directed by the Oncologist.

Product Details:

Lyophilized For I.V. Infusion Only To be dilulted prior to intravenous administration

Product Details:

Product Details:

Product Details:

Product Details:

Product Details:

Product Details:

Product Details:

Subcutaneous Use

Product Details:

Product Details:

Lenvatinib is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases

LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.

It is not known if LENVIMA is safe and effective in children

LENVIMA is a prescription medicine that is used to treat certain kinds of cancer.

• LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.
• LENVIMA is used along with another medicine called everolimus to treat advanced renal cell carcinoma (RCC), a type of kidney cancer, after one course of treatment with another anti-cancer medicine.
• LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.

It is not known if LENVIMA is safe and effective in children.

The most common side effects of LENVIMA in people treated for thyroid cancer include tiredness; joint and muscle pain; decreased appetite; weight loss; nausea; mouth sores; headache; vomiting; rash, redness, itching, or peeling of your skin on your hands and feet; stomach (abdomen) pain; and hoarseness.

The most common side effects of LENVIMA in people treated for kidney cancer include tiredness, joint and muscle pain, decreased appetite, vomiting, nausea, mouth sores, swelling in your arms and legs, cough, stomach (abdomen) pain, trouble breathing, rash, weight loss, and bleeding.

The most common side effects of LENVIMA in people treated for liver cancer include tiredness; decreased appetite; joint and muscle pain; weight loss; stomach (abdomen) pain; rash, redness, itching, or peeling of your skin on your hands and feet; hoarseness; bleeding; change in thyroid hormone levels; nausea.

Product Details: